TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Mid-Size Pharmaceutical – By Type
1.3.2 Global Mid-Size Pharmaceutical – By Drug Development Type
1.3.3 Global Mid-Size Pharmaceutical – By Formulation
1.3.4 Global Mid-Size Pharmaceutical – By Therapy Area
1.3.5 Global Mid-Size Pharmaceutical – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Mid-Size Pharmaceutical – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East & Africa – PEST Analysis
4.2.5 South & Central America – PEST Analysis
4.3 Expert Opinion
5. Mid-Size Pharmaceutical Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Disorders
5.1.2 Increasing Product Approval and Launches
5.2 Market Restraints
5.2.1 Cutthroat Competition among Market Players
5.3 Market Opportunities
5.3.1 Rising Number of Healthcare Start-ups
5.4 Future Trends
5.4.1 Greater Focus on R&D
5.5 Impact Analysis
6. Mid-Size Pharmaceutical Market– Global Analysis
6.1 Global Mid-Size Pharmaceutical Market Revenue Forecast And Analysis
6.1.1 Global Mid-Size Pharmaceutical Market Revenue Forecast And Analysis
6.1.2 Global Mid-Size Pharmaceutical Market – Market Potential Analysis, By Region
6.2 Market Positioning Analysis Of Key Players In Mid-Size Pharmaceutical Market
6.2.1 Company Analysis
6.2.2 Growth Strategy Analysis
6.2.3 Performance Of Key Players
6.2.3.1 Regeneron Pharmaceuticals, Inc.
6.2.3.2 DAIICHI SANKYO COMPANY LIMITED
7. Global Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type
7.1 Overview
7.2 Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)
7.3 Prescription
7.3.1 Overview
7.3.2 Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Over-the-Counter (OTC)
7.4.1 Overview
7.4.2 Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8. Mid-Size Pharmaceutical Market Analysis – By Drug Development Type
8.1 Overview
8.2 Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)
8.3 In-House
8.3.1 Overview
8.3.2 In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Outsource
8.4.1 Overview
8.4.2 Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9. Mid-Size Pharmaceutical Market – By Formulation
9.1 Overview
9.2 Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)
9.3 Tablets and Capsules
9.3.1 Overview
9.3.2 Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Injectables
9.4.1 Overview
9.4.2 Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Sprays
9.5.1 Overview
9.5.2 Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Other Formulations
9.6.1 Overview
9.6.2 Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10. Mid-Size Pharmaceutical Market – By Therapy Class
10.1 Overview
10.2 Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)
10.3 Cardiovascular Diseases
10.3.1 Overview
10.3.2 Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Pain Management
10.4.1 Overview
10.4.2 Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Diabetes
10.5.1 Overview
10.5.2 Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Cancer
10.6.1 Overview
10.6.2 Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Other Diseases
10.7.1 Overview
10.7.2 Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11. Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 North America: Mid-Size Pharmaceutical Market
11.1.1 Overview
11.1.2 North America: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3 North America: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million)
11.1.4 North America: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million)
11.1.5 North America: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million)
11.1.6 North America: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million)
11.1.7 North America: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)
11.1.7.1 US: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.3 US: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million)
11.1.7.1.4 US: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million)
11.1.7.1.5 US: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million)
11.1.7.1.6 US: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million)
11.1.7.2 Canada: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.3 Canada: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million)
11.1.7.2.4 Canada: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million)
11.1.7.2.5 Canada: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million)
11.1.7.2.6 Canada: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million)
11.1.7.3 Mexico: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.3 Mexico: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million)
11.1.7.3.4 Mexico: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million)
11.1.7.3.5 Mexico: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million)
11.1.7.3.6 Mexico: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million)
11.2 Europe: Mid-Size Pharmaceutical Market
11.2.1 Overview
11.2.2 Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.2.4 Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.2.4.1 Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.2.4.2 Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.2.5 Europe: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)
11.2.5.1 Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.2.5.1.1 Overview
11.2.5.1.2 Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.2.5.1.3 Germany: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.2.5.1.4 Germany: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.2.5.1.5 Germany: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.2.5.1.6 Germany: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.2.5.2 France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.2.5.2.1 Overview
11.2.5.2.2 France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.2.5.2.3 France: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.2.5.2.4 France: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.2.5.2.5 France: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.2.5.2.6 France: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.2.5.3 UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.2.5.3.1 Overview
11.2.5.3.2 UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.2.5.3.3 UK: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.2.5.3.4 UK: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.2.5.3.5 UK: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.2.5.3.6 UK: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.2.5.4 Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.2.5.4.1 Overview
11.2.5.4.2 Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.2.5.4.3 Italy: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.2.5.4.4 Italy: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.2.5.4.5 Italy: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.2.5.4.6 Italy: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.2.5.5 Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.2.5.5.1 Overview
11.2.5.5.2 Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.2.5.5.3 Spain: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.2.5.5.4 Spain: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.2.5.5.5 Spain: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.2.5.5.6 Spain: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.2.5.6 Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.2.5.6.1 Overview
11.2.5.6.2 Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.2.5.6.3 Rest of Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.2.5.6.4 Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.2.5.6.5 Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.2.5.6.6 Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.3 Asia Pacific: Mid-Size Pharmaceutical Market
11.3.1 Overview
11.3.2 Asia Pacific: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million)
11.3.3.1 Asia Pacific: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million)
11.3.3.2 Asia Pacific: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)
11.3.4 Asia Pacific: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)
11.3.5 Asia Pacific: Mid-Size Pharmaceutical Market, by Country, 2022 & 2028 (%)
11.3.5.1 China: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.3.5.1.1 China: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.3.5.1.2 China: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million)
11.3.5.1.3 China: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million)
11.3.5.1.4 China: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)
11.3.5.1.5 China: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)
11.3.5.2 Japan: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.3.5.2.1 Japan: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.3.5.2.2 Japan: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million)
11.3.5.2.3 Japan: Mid-Size Pharmaceutical Market, By Drug Development Type , 2019–2028 (USD Million)
11.3.5.2.4 Japan: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)
11.3.5.2.5 Japan: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)
11.3.5.3 India: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.3.5.3.1 India: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.3.5.3.2 India: Mid-Size Pharmaceutical Market, By Type , 2019–2028 (USD Million)
11.3.5.3.3 India: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million)
11.3.5.3.4 India: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)
11.3.5.3.5 India: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)
11.3.5.4 Australia: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.3.5.4.1 Australia: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.3.5.4.2 Australia: Mid-Size Pharmaceutical Market , By Type , 2019–2028 (USD Million)
11.3.5.4.3 Australia: Mid-Size Pharmaceutical Market , By Drug Development Type , 2019–2028 (USD Million)
11.3.5.4.4 Australia: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)
11.3.5.4.5 Australia: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)
11.3.5.5 South Korea: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.3.5.5.1 South Korea: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.3.5.5.2 South Korea: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million)
11.3.5.5.3 South Korea: Mid-Size Pharmaceutical Market, By Drug Development Type , 2019–2028 (USD Million)
11.3.5.5.4 South Korea: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)
11.3.5.5.5 South Korea: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)
11.3.5.6 Rest of Asia Pacific: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.3.5.6.1 Rest of Asia Pacific: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.3.5.6.2 Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million)
11.3.5.6.3 Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million)
11.3.5.6.4 Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)
11.3.5.6.5 Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)
11.4 Middle East & Africa Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028
11.4.1 Overview
11.4.2 Middle East & Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.3 Middle East & Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
11.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)
11.4.4.1 Middle East & Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.4.4.2 Middle East & Africa: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.4.5 Middle East & Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Country (%)
11.4.5.1 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.1.1 Overview
11.4.5.1.2 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.1.3 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
11.4.5.1.4 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)
11.4.5.1.5 UAE: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.4.5.1.6 UAE: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.4.5.2 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.2.1 Overview
11.4.5.2.2 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.2.3 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
11.4.5.2.4 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)
11.4.5.2.5 Saudi Arabia: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.4.5.2.6 Saudi Arabia: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.4.5.3 South Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.3.1 Overview
11.4.5.3.2 South Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.3.3 South Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
11.4.5.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)
11.4.5.3.5 South Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.4.5.3.6 South Africa: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.4.5.4 Rest of Middle East and Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.4.1 Overview
11.4.5.4.2 Rest of Middle East and Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)
11.4.5.4.3 Rest of Middle East & Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
11.4.5.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)
11.4.5.4.5 Rest of Middle East and Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.4.5.4.6 Rest of Middle East and Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.5 South & Central America: Mid-Size Pharmaceutical Market
11.5.1 Overview
11.5.2 South and Central America: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.5.3 South and Central America: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million)
11.5.4 South and Central America: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million)
11.5.5 South and Central America: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million)
11.5.6 South and Central America: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million)
11.5.7 South and Central America: Mid-Size Pharmaceutical Market, by country, 2021 & 2028 (%)
11.5.7.1 Brazil: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.1 Brazil: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.2 Brazil: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million)
11.5.7.1.3 Brazil: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million)
11.5.7.1.4 Brazil: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million)
11.5.7.1.5 Brazil: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million)
11.5.7.2 Argentina: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.1 Argentina: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.2 Argentina: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million)
11.5.7.2.3 Argentina: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million)
11.5.7.2.4 Argentina: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million)
11.5.7.2.5 Argentina: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million)
11.5.7.3 Rest of South and Central America: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.1 Rest of South and Central America: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.2 Rest of South and Central America: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million)
11.5.7.3.3 Rest of South and Central America: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million)
11.5.7.3.4 Rest of South and Central America: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million)
11.5.7.3.5 Rest of South and Central America: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Mid-Size Pharmaceutical Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Mid-Size Pharmaceutical Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 DAIICHI SANKYO COMPANY LIMITED
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Eisai Co., Ltd.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Bausch Health Companies Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Regeneron Pharmaceuticals, Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Sun Pharmaceutical Industries Ltd
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Alexion Pharmaceuticals, Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Mallinckrodt
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Endo Pharmaceuticals Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Les Laboratories Servier
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 UCB S.A.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES.
Table 1. North America Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Mid-Size Pharmaceutical Market, by Formulation– Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Mid-Size Pharmaceutical Market, by Therapy Area– Revenue and Forecast to 2028 (US$ Million)
Table 5. US Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 7. US Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 21. Germany: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Germany: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 25. France: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. France: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 27. France: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 28. France: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 29. UK: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 30. UK: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 31. UK: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 45. Asia Pacific: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 46. Asia Pacific: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and forecast to 2028 (US$ Million)
Table 47. Asia Pacific: Mid-Size Pharmaceutical Market, By Formulation – Revenue and forecast to 2028 (US$ Million)
Table 48. Asia Pacific: Mid-Size Pharmaceutical Market, By Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 49. China: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 50. China: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and forecast to 2028 (US$ Million)
Table 51. China: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 52. China: Mid-Size Pharmaceutical Market , By Therapy Area– Revenue and Forecast to 2028 (US$ Million)
Table 53. Japan: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 54. Japan: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (US$ Million)
Table 55. Japan: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 56. Japan: Mid-Size Pharmaceutical Market , By Therapy Area– Revenue and Forecast to 2028 (US$ Million)
Table 57. India: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 58. India: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (US$ Million)
Table 59. India: Mid-Size Pharmaceutical Market, By Formulation - Revenue and Forecast to 2028 (US$ Million)
Table 60. India: Mid-Size Pharmaceutical Market, By Therapy Area– Revenue and Forecast to 2028 (US$ Million)
Table 61. Australia: Mid-Size Pharmaceutical Market , By Type – Revenue and Forecast to 2028 (US$ Million)
Table 62. Australia: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (US$ Million)
Table 63. Australia: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 64. Australia: Mid-Size Pharmaceutical Market, By Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 65. South Korea: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 66. South Korea: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (US$ Million)
Table 67. South Korea: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 68. South Korea: Mid-Size Pharmaceutical Market, By Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 70. Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (US$ Million)
Table 71. Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 72. Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 73. Middle East & Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 74. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)
Table 75. Middle East & Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 76. Middle East & Africa: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 77. UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 78. UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)
Table 79. UAE: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 80. UAE: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 81. Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 82. Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)
Table 83. Saudi Arabia: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 84. Saudi Arabia: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 85. South Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 86. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)
Table 87. South Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 88. South Africa: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 89. Rest of Middle East & Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 90. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)
Table 91. Rest of Middle East and Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 92. Rest of Middle East and Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 93. South and Central America: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 94. South and Central America: Mid-Size Pharmaceutical Market, by Drug Development Type – Revenue and Forecast to 2028 (US$ Million)
Table 95. South and Central America: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 96. South and Central America: Mid-Size Pharmaceutical Market, by Therapy Area– Revenue and Forecast to 2028 (US$ Million)
Table 97. Brazil: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 98. Brazil: Mid-Size Pharmaceutical Market, by Drug Development Type – Revenue and Forecast to 2028 (US$ Million)
Table 99. Brazil: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 100. Brazil: Mid-Size Pharmaceutical Market, by Therapy Area– Revenue and Forecast to 2028 (US$ Million)
Table 101. Argentina: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 102. Argentina: Mid-Size Pharmaceutical Market, by Drug Development Type – Revenue and Forecast to 2028 (US$ Million)
Table 103. Argentina: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 104. Argentina: Mid-Size Pharmaceutical Market, by Therapy Area– Revenue and Forecast to 2028 (US$ Million)
Table 105. Rest of South and Central America: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 106. Rest of South and Central America: Mid-Size Pharmaceutical Market, by Drug Development Type – Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of South and Central America: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of South and Central America: Mid-Size Pharmaceutical Market, by Therapy Area– Revenue and Forecast to 2028 (US$ Million)
Table 109. Organic Developments Done By Companies
Table 110. Inorganic Developments Done By Companies
Table 111. Glossary of Terms
